(PharmaNewsWire.Com, February 22, 2018 ) Asia Pacific Anti Snoring Devices Market Size is anticipated to grow at 11.54% CAGR from 2017 to 2022 and it is estimated that the Asia Pacific market was valued at USD 0.13 billion in 2017 and is expected to reach USD 0.23 billion by 2022.Snoring is common sleep disorders is a result of the repetitive narrowing and collapsing of the upper airway. Untreated snoring is often associated with multiple adverse health outcomes including systemic hypertension, coronary artery disease, stroke and atrial fibrillation. Snoring is also considered as a significant social problem and leads to a poorer quality of life for bed partners through disrupted sleep. Treatment for snoring involves either anti-snoring devices or by doing an appropriate surgery. Common surgery includes uvulopalatopharyngoplasty surgery, tonsillectomy and adenoidectomy surgery, maxillo-mandibular and genioglossus advancement surgeries, radiofrequency ablation surgery.
Some major factors stimulating the market growth are an increase in the awareness among individuals about the ill effects of snoring, soaring geriatric and obese population, the presence of an untapped population pool characterized by a snoring condition, and the increasing consumption of alcohol and cigarettes. The subsequent health risks associated with this condition are sleep apnea, interrupted breathing, and strain on the heart. These conditions have stimulated the population to opt for treatment solutions including non-surgical appliances and surgical options, which in turn has led to the growth of the overall industry. Be that as it may, factors, such as the high-cost of these surgeries, limited efficacy of the current treatments available for this condition, and unpropitious reimbursement issues are likely to deter the growth of the anti-snoring devices and snoring surgery market. Moreover, disadvantages to the use of the non-surgical equipment, such as dry mouth, jaw discomfort, and hyper salivation serve as strong deterrents that discourage their use among the patients.
Asia Pacific Anti Snoring Devices Market Segmentation by Device Type and Surgical Procedure. On the basis of Device Type, it is segmented MADs, TRD, Nasal Dilator, Chin Strap, Position Control, Pillows, TSD, and EPAP. The oral appliances segment is expected to account for the largest share of the market, followed by the nasal devices segment. The oral appliances segment is projected to register the highest CAGR during the forecast period, due to the growth in awareness among dentists and patients regarding the use of oral appliances, a recommendation as the first line of anti-snoring treatment from health organizations in several regions, and launch of new and advanced products. On the basis of Surgical Procedure, it is segmented UP3, LAUP, RFA, Sclerotherapy, Pillar, and Others.
Asia Pacific Anti Snoring Devices Market geographical segmentation by India, China, Japan, Australia and South Korea. Asia Pacific is anticipated to register the highest growth rate due to an availability of large pool of untreated individuals with a snoring condition and the high level of awareness associated with this condition.
The major Asia Pacific Anti Snoring Devices Market leaders are Sleeping Well LLC, Apnea Sciences Corporation, Tomed Dr. Toussaint Gmbh, AccuMED Corp., Fisher & Paykel Healthcare, Apnea Sciences Corporation, ImThera Medical Inc., ResMed Inc., SomnoMed, Sleep Well Enjoy Life, Ltd., MEDiTAS Ltd., and Nasal Devices.
Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
About Market data forecast Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
